The Functional Effects of Intramural Course of Coronary Arteries and its Relation to Coronary Atherosclerosis

Valtteri Uusitalo1, Antti Saraste2, Mikko Pietilä3

  • 1Turku PET Centre, Turku University Hospital, University of Turku, Turku, Finland.

Insights

Myocardial bridging, a common finding on computed tomography angiography (CTA), does not reduce myocardial perfusion. Atherosclerosis is typically found proximal to myocardial bridges, but the overall burden is comparable.

Area of Science:

  • Cardiology
  • Radiology
  • Medical Imaging

Background:

  • Myocardial bridging involves an intramural course of coronary arteries, identified by computed tomography angiography (CTA) or systolic compression via invasive coronary angiography.
  • Previous research suggests a link between myocardial bridging and proximal atherosclerotic plaques.

Purpose of the Study:

  • To investigate the hemodynamic effects of myocardial bridging.
  • To examine the relationship between myocardial bridging and coronary atherosclerosis.

Main Methods:

  • Prospective study of 100 patients with intermediate likelihood of coronary artery disease.
  • Identification of myocardial bridging segments using CTA.
  • Assessment of myocardial perfusion with 15-Oxygen water positron emission tomography.
  • Evaluation of systolic compression through invasive coronary angiography.

Main Results:

  • Myocardial bridging was detected in 34% of patients, with deep bridging in 50% of these cases.
  • No significant difference in myocardial stress perfusion was observed distal to myocardial bridging compared to remote regions.
  • Atherosclerotic plaques were more frequent proximally to myocardial bridging, but overall atherosclerosis burden and vulnerable plaque presence were comparable between bridged and non-bridged arteries.

Conclusions:

  • Myocardial bridging is frequently identified on CTA, though systolic compression is less common.
  • Myocardial bridging is not associated with impaired myocardial perfusion during vasodilator stress.
  • Atherosclerosis predominantly occurs proximal to myocardial bridges, with similar burden and plaque characteristics observed in bridged and non-bridged coronary arteries.
Abstract

Related Concept Videos

Coronary Artery Disease II: Pathophysiology01:26

Coronary Artery Disease II: Pathophysiology

Coronary Artery Disease (CAD) originates from a series of events that impair the function of coronary arteries, the blood vessels responsible for delivering oxygen-rich blood to the heart muscle. The pathophysiology of CAD is closely linked to atherosclerosis, a chronic inflammatory and lipid-driven condition affecting the vascular endothelium.1. Endothelial DamageThe process begins with damage to the vascular endothelium, which serves as a protective barrier between the blood and the vessel...
1.0K
Coronary Artery Disease I: Introduction01:30

Coronary Artery Disease I: Introduction

Coronary Artery Disease (CAD): An Overview with Scientific InsightsCoronary Artery Disease (CAD), often referred to as C-A-D, is a prevalent blood vessel disorder classified under the broader category of atherosclerosis. Atherosclerosis is a pathological process characterized by the hardening and narrowing of arteries due to the accumulation of atherosclerotic plaques. These plaques are composed of cholesterol, fatty substances, inflammatory cells, calcium, and fibrin, reducing blood flow to...
1.7K
Atherosclerosis I: Introduction01:30

Atherosclerosis I: Introduction

Atherosclerosis is a progressive disorder characterized by the buildup of plaques on the arterial inner wall, causing them to narrow and harden over time. These plaques comprise lipids, calcium, blood components, carbohydrates, and fibrous tissue. The process primarily affects the intima of large and medium-sized arteries, reducing blood flow in any artery.Etiology and risk factorsThe cause of atherosclerosis is multifactorial, involving a complex interplay among endothelial injury, lipid...
2.1K
Coronary Artery Disease IV: Preventive Measures01:26

Coronary Artery Disease IV: Preventive Measures

Effective preventive measures for coronary artery disease (CAD) focus on controlling modifiable risk factors, including cholesterol abnormalities and lifestyle changes.Cholesterol ManagementFirst, the Mediterranean diet and the American Heart Association advocate for maintaining low-density lipoprotein (LDL) cholesterol levels below 100 mg/dL, with a more stringent recommendation of below 70 mg/dL for individuals at high risk. LDL cholesterol, often termed "bad cholesterol," can lead to the...
866
Coronary Artery Disease V: Interprofessional Care01:27

Coronary Artery Disease V: Interprofessional Care

Interprofessional care for coronary artery disease includes pharmacological therapy and revascularization procedures.Pharmacological therapy for Coronary Artery Disease (CAD) aims to manage symptoms, prevent complications, and improve patient outcomes through various classes of medications:Antiplatelet Agents:Aspirin and Clopidogrel: These medications inhibit platelet aggregation, preventing blood clots, which is crucial for avoiding heart attacks and strokes. Doctors often prescribe these...
423
Atherosclerosis II: Clinical Manifestations and Diagnostic Tests01:27

Atherosclerosis II: Clinical Manifestations and Diagnostic Tests

Atherosclerosis is a progressive disorder that leads to the thickening and narrowing of arterial walls due to plaque buildup. This condition can cause various symptoms depending on the arteries affected:Coronary Artery Disease (CAD): This condition affects the coronary arteries and may lead to chest pain (angina), shortness of breath (dyspnea), heart attacks, and other heart disease symptoms.Cerebrovascular Disease: This affects blood flow to the brain, causing transient ischemic attacks (TIAs)...
784